Microcirculation on a Large Scale: Techniques, Tactics and Relevance of Studying the Microcirculation in Larger Population Samples

Microcirculation

Volumn 19, Issue 1, 2012, Pages 37-46

  Strain, W David ^a   Adingupu, Damilola D ^a   Shore, Angela C ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Cardiovascular disease; Clinical results; Epidemiology; Microcirculation

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL RESEARCH; COHORT ANALYSIS; DIABETES MELLITUS; HUMAN; HYPERTENSION; MICROCIRCULATION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; RETINOPATHY; REVIEW; RISK FACTOR; STROKE;

AGED; CARDIOVASCULAR DISEASES; HUMANS; MICROCIRCULATION; RISK FACTORS;

EID: 84155184308     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2011.00140.x     Document Type: Review

References (77)

1. Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 89: 175, 2003.
2. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34(4 Pt. 1): 655-658, 1999.
3. Arun CS, Al-Bermani A, Stannard K, Taylor R. Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med 26(5): 489-492, 2009.
4. Atthobari J, Asselbergs FW, Boersma C, de Vries R, Hillege HL, van Gilst WH, Gansevoort RT, de Jong PE, de Jong-van den Berg LT, Postma MJ. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: a pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT). Clin Ther 28(3): 432-444, 2006.
5. Bernardinelli L, de Marco R, Tinelli C. Cancer mortality in an Italian rubber factory. Br J Industr Med 44(3): 187-191, 1987.
6. van den Born BJ, Hulsman CA, Hoekstra JB, Schlingemann RO, van Montfrans GA. Value of routine funduscopy in patients with hypertension: systematic review. BMJ 331(7508): 73, 2005.
7. Bottcher M, Madsen MM, Refsgaard J, Buus NH, Dorup I, Nielsen TT, Sorensen K. Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve. Circulation 103(8): 1109-1114, 2001.
8. Branten AJ, Smits P, Jansen TL, Wollersheim H, Thien T. Effect of atrial natriuretic factor on skin microcirculation versus skeletal muscle blood flow. J Cardiovasc Pharmacol 27(2): 303-306, 1996.
9. Brantsma AH, Atthobari J, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. What predicts progression and regression of urinary albumin excretion in the nondiabetic population? J Am Soc Nephrol 18(2): 637-645, 2007.
10. Buggy D, Feely J, Murphy J, O'Sullivan C, Walsh M. Microalbuminuria and coronary heart disease in non-diabetics. Postgrad Med J 69: 704, 1993.
11. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48(9): 1856-1862, 1999.
12. Carpentier PH. New techniques for clinical assessment of the peripheral microcirculation. Drugs 59 Spec No.: 17-22, 1999.
13. Chien S. Effects of disturbed flow on endothelial cells. Ann Biomed Eng 36(4): 554-562, 2008.
14. Choi CM, Bennett RG. Laser Dopplers to determine cutaneous blood flow. Dermatol Surg 29(3): 272-280, 2003.
15. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 321(16): 1074-1079, 1989.
16. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 300(6720): 297-300, 1990.
17. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. Br Med J 1(4877): 1451-1455, 1954.
18. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286(4): 421-426, 2001.
19. Goligorsky MS. Endothelial cell dysfunction: can't live with it, how to live without it. Am J Physiol Renal Physiol 288(5): F871-F880, 2005.
20. Gordon T, Kannel WB. Predisposition to atherosclerosis in the head, heart, and legs. The Framingham study. JAMA 221: 661, 1972.
21. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339(4): 229-234, 1998.
22. Hannemann MM, Liddell WG, Shore AC, Clark PM, Tooke JE. Vascular function in women with previous gestational diabetes mellitus. J Vasc Res 39(4): 311-319, 2002.
23. Hansen PR, Haunso S. Effects of nitric oxide synthase inhibition on myocardial capillary permeability and reactive hyperaemic response. Cardiovasc Res 29(6): 862-866, 1995.
24. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 21(8): 1230-1235, 1998.
25. Hill AB. The environment and disease: association or causation? Proc R Soc Med 58: 295-300, 1965.
26. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106(14): 1777-1782, 2002.
27. Ijzerman RG, de Jongh RT, Beijk MA, van Weissenbruch MM, Delemarre-van de Waal HA, Serne EH, Stehouwer CD. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 33(7): 536-542, 2003.
28. Jaap AJ, Hammersley MS, Shore AC, Tooke JE. Reduced microvascular hyperaemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 37(2): 214-216, 1994.
29. Jaap AJ, Pym CA, Seamark C, Shore AC, Tooke JE. Microvascular function in type 2 (non-insulin-dependent) diabetes: improved vasodilation after one year of good glycaemic control. Diabet Med 12(12): 1086-1091, 1995.
30. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124(1 Pt. 2): 164-169, 1996.
31. de Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant 18(1): 10-13, 2003.
32. Joyner MJ, Dietz NM, Shepherd JT. From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J Appl Physiol 91(6): 2431-2441, 2001.
33. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 30(2): 292-299, 2007.
34. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122(4): 552-563, 2004.
35. Kimmelstiel P, Wilson C. Benign and malignant hypertension and nephrosclerosis: a clinical and pathological study. Am J Pathol 12(1): 45-82, 1936.
36. Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 260(3): 231-237, 2006.
37. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY, Brancati FL, Hubbard LD, Couper D. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 109(7): 1225-1234, 2002.
38. Liew G, Wong TY, Mitchell P, Cheung N, Wang JJ. Retinopathy predicts coronary heart disease mortality. Heart 95(5): 391-394, 2009.
39. Lucas J, Schiller J, Benson V. Summary health statistics for U.S. adults: National Health Interview Survey, 2001. National Center for Health Statistics, Vital Health Stat 10(218): 1-134, 2004.
40. McMillan DE. Deterioration of the microcirculation in diabetes. Diabetes 24(10): 944-957, 1975.
41. Movshovitz M, Modan B. Role of sun exposure in the etiology of malignant melanoma: epidemiologic inference. J Natl Cancer Inst 51(3): 777-779, 1973.
42. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24): 2457-2471, 2007.
43. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 99(8): 1873-1879, 1997.
44. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323(1): 22-27, 1990.
45. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32(9): 943-949, 1983.
46. Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health 50(3): 334-339, 1996.
47. Rossi M, Taddei S, Fabbri A, Tintori G, Credidio L, Virdis A, Ghiadoni L, Salvetti A, Giusti C. Cutaneous vasodilation to acetylcholine in patients with essential hypertension. J Cardiovasc Pharmacol 29(3): 406-411, 1997.
48. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Company, 1986.
49. Sandeman DD, Pym CA, Green EM, Seamark C, Shore AC, Tooke JE. Microvascular vasodilatation in feet of newly diagnosed non-insulin dependent diabetic patients. BMJ 302(6785): 1122-1123, 1991.
50. Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 327(11): 760-764, 1992.
51. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5(2): 126-134, 1988.
52. Serre K, Sasongko MB. Modifiable Lifestyle and Environmental Risk Factors Affecting the Retinal Microcirculation. Microcirculation 19(1): 29-36, 2012.
53. Sieg-Dobrescu D, Burnier M, Hayoz D, Brunner HR, Waeber B. The return of increased blood pressure after discontinuation of antihypertensive treatment is associated with an impaired post-ischemic skin blood flow response. J Hypertens 19(8): 1387-1392, 2001.
54. Strain WD, Chaturvedi N, Bulpitt CJ, Rajkumar C, Shore AC. Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes 54(6): 1816-1822, 2005.
55. Strain WD, Chaturvedi N, Hughes A, Nihoyannopoulos P, Bulpitt CJ, Rajkumar C, Shore AC. Associations between cardiac target organ damage and microvascular dysfunction: the role of blood pressure. J Hypertens 28(5): 952-8, 2010.
56. Strain WD, Chaturvedi N, Leggetter S, Nihoyannopoulos P, Rajkumar C, Bulpitt CJ, Shore AC. Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 23(1): 133-140, 2005.
57. Strain WD, Chaturvedi N, Nihoyannopoulos P, Bulpitt CJ, Rajkumar C, Shore AC. Differences in the association between type 2 diabetes and impaired microvascular function among Europeans and African Caribbeans. Diabetologia 48(11): 2269-2277, 2005.
58. Strain WD, Hughes AD, Mayet J, Wright AR, Kooner J, Chaturvedi N, Shore AC. Attenuation of microvascular function in those with cardiovascular disease is similar in patients of Indian Asian and European descent. BMC Cardiovasc Disord 10: 3, 2010.
59. Strain WD, Shore AC, Melzer D. Albumin:creatinine ratio predicts mortality after stroke: analysis of the NHANES III. J Am Geriatr Soc 58(12): 2434-2435, 2010.
60. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Endothelial dysfunction in hypertension. J Cardiovasc Pharmacol 38(Suppl. 2): S11-S14, 2001.
61. Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med 25(1): 45-50, 2008.
62. Thomson JG, Kaschula RO, Macdonald RR. Asbestos as a modern urban hazard. South Afr Med J = Suid-Afrikaanse tydskrif vir geneeskunde 37: 77-81, 1963.
63. Tooke JE. Microvascular haemodynamics in diabetes mellitus. Clin Sci (Lond) 70(2): 119-125, 1986.
64. Tooke JE, Lins PE, Ostergren J, Fagrell B. Skin microvascular autoregulatory responses in type I diabetes: the influence of duration and control. Int J Microcirc Clin Exp 4(3): 249-256, 1985.
65. Vinik AI, Stansberry KB, Barlow PM. Rosiglitazone treatment increases nitric oxide production in human peripheral skin: a controlled clinical trial in patients with type 2 diabetes mellitus. J Diabetes Complications 17(5): 279-285, 2003.
66. Wild S, McKeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. Br Med J 314(7082): 705-710, 1997.
67. Williams SA, Tooke JE. Noninvasive estimation of increased structurally-based resistance to blood flow in the skin of subjects with essential hypertension. Int J Microcirc Clin Exp 11(1): 109-116, 1992.
68. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, Wofford MR, Sharrett AR. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358(9288): 1134-1140, 2001.
69. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288(1): 67-74, 2002.
70. Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, Klein BE, Hubbard LD, Duncan BB. Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA 287(19): 2528-2533, 2002.
71. Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, Folsom AR, Klein R. Retinopathy and risk of congestive heart failure. JAMA 293(1): 63-69, 2005.
72. Yamamoto-Suganuma R, Aso Y. Relationship between post-occlusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes-a novel index for detecting micro- and macrovascular dysfunction using laser Doppler flowmetry. Diabet Med 26(1): 83-88, 2009.
73. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 2(8610): 530-533, 1988.
74. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22): 2746-2753, 2001.
75. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104(23): 2855-2864, 2001.
76. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 255(2): 247-256, 2004.
77. Yvonne-Tee GB, Rasool AH, Halim AS, Rahman AR. Reproducibility of different laser Doppler fluximetry parameters of postocclusive reactive hyperemia in human forearm skin. J Pharmacol Toxicol Methods 52(2): 286-292, 2005.